Stocktoria
Jade Biosciences, Inc. JBIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-06-30
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$113.5M | -$74.6M | -$81.4M | -$53.2M | -$23.0M |
| Net income | -$127.4M | -$69.6M | -$75.5M | -$51.5M | -$23.0M |
| Operating cash flow | -$94.7M | -$71.2M | -$56.8M | -$39.1M | -$27.4M |
| Free cash flow | -$94.9M | — | -$56.9M | -$39.3M | -$27.6M |
| Total assets | $349.8M | $72.8M | $127.4M | $135.3M | $175.4M |
| Total liabilities | $17.3M | $119.6M | $18.0M | $8.6M | $2.9M |
| Shareholders' equity | $332.5M | -$46.8M | $109.5M | $126.7M | $172.4M |
| Ratios | |||||
| Return on assets | -36.4% | -95.6% | -59.3% | -38.1% | -13.1% |
| Return on equity | -38.3% | 148.8% | -69.0% | -40.6% | -13.3% |
| Current ratio | 21.09 | 5.81 | 7.04 | 16.90 | 68.37 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 286,715 | $4.0M |
| RENAISSANCE TECHNOLOGIES LLC | 135,039 | $1.9M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001798749 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.